A6Q-15840-32264
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-05
Survey response — day 7, dose 1MedDRA: Injection site urticaria, Self-medication, Vaccination site reaction — Feeling: Good · Site: Swelling, ItchingFree text: Large urticarial plaque at injection site approximately 4 to 5 cm. It is responsive to antihistamines. Clinically consistent with delayed localized injection reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Medical counselling, Office visit, Type IV hypersensitivity reaction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Significant localized injection site reaction onset at day seven. Marked swelling and pain. Area of erythema and swelling approximately 20 x 10 cm lasting several days. Findings consistent with type for delayed hypersensitivity localized reaction. · Healthcare visit (other): Saw a colleague who is an allergist to confirm my suspicionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-19
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-02-25
- 2021-02-27
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-11-05
Dose 3 — Moderna
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Chest discomfort, Headache, Myalgia, Nausea, Pyrexia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Post vaccine fever, myalgias, nausea, severe headache lasting 36 hrs. 3 days after the booster I Developed chest pressure which lasted a weekMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-27
- 2022-05-06
- 2022-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Large urticarial plaque at injection site approximately 4 to 5 cm. It is responsive to antihistamines. Clinically consistent with delayed localized injection reaction
Release 1 — day 14, dose 1
Symptoms: Significant localized injection site reaction onset at day seven. Marked swelling and pain. Area of erythema and swelling approximately 20 x 10 cm lasting several days. Findings consistent with type for delayed hypersensitivity localized reaction.
Healthcare visit (other): Saw a colleague who is an allergist to confirm my suspicion
Release 11 — 12 months, dose 2
Symptoms: Post vaccine fever, myalgias, nausea, severe headache lasting 36 hrs. 3 days after the booster I Developed chest pressure which lasted a week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | · | ✓ |
| HCVO | Office visit | ○ | ✓ | ○ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ○ | ✓ | ○ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Type IV hypersensitivity reaction | ✓ | ✓ | ✓ |
| SRO | Injection site urticaria | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Vaccination site reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release